These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38018953)

  • 41. A Potential Role for the Ketogenic Diet in Alzheimer's Disease Treatment: Exploring Pre-Clinical and Clinical Evidence.
    Oliveira TPD; Morais ALB; Dos Reis PLB; Palotás A; Vieira LB
    Metabolites; 2023 Dec; 14(1):. PubMed ID: 38248828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of the ketogenic diet on the elemental and biochemical compositions of the hippocampal formation.
    Chwiej J; Skoczen A; Matusiak K; Janeczko K; Patulska A; Sandt C; Simon R; Ciarach M; Setkowicz Z
    Epilepsy Behav; 2015 Aug; 49():40-6. PubMed ID: 25986320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement.
    Ota M; Matsuo J; Ishida I; Hattori K; Teraishi T; Tonouchi H; Ashida K; Takahashi T; Kunugi H
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3797-3802. PubMed ID: 27568199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Ketogenic diet – mechanism of action and perspectives for the use in the therapy: data from clinical studies].
    Pondel N; Liśkiewicz D; Liśkiewicz A
    Postepy Biochem; 2020 Sep; 66(3):270-286. PubMed ID: 33315315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders.
    Spigoni V; Cinquegrani G; Iannozzi NT; Frigeri G; Maggiolo G; Maggi M; Parello V; Dei Cas A
    Front Endocrinol (Lausanne); 2022; 13():972890. PubMed ID: 36339405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A ketogenic diet differentially affects neuron and astrocyte transcription.
    Koppel SJ; Pei D; Wilkins HM; Weidling IW; Wang X; Menta BW; Perez-Ortiz J; Kalani A; Manley S; Novikova L; Koestler DC; Swerdlow RH
    J Neurochem; 2021 Jun; 157(6):1930-1945. PubMed ID: 33539571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease.
    Ramezani M; Fernando M; Eslick S; Asih PR; Shadfar S; Bandara EMS; Hillebrandt H; Meghwar S; Shahriari M; Chatterjee P; Thota R; Dias CB; Garg ML; Martins RN
    Front Neurosci; 2023; 17():1297984. PubMed ID: 38033541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Supplementation with medium-chain fatty acids increases body weight loss during very low-calorie ketogenic diet: a retrospective analysis in a real-life setting.
    Vetrani C; Verde L; Savastano S; Colao A; Muscogiuri G; Barrea L
    J Transl Med; 2023 Jan; 21(1):29. PubMed ID: 36647097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ketone bodies as a therapeutic for Alzheimer's disease.
    Henderson ST
    Neurotherapeutics; 2008 Jul; 5(3):470-80. PubMed ID: 18625458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease).
    Włodarek D
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30650523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
    VanItallie TB
    Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ketogenic Approaches for the Treatment of Alzheimer's Disease.
    Gabuzyan R; Lee C; Nygaard HB
    J Alzheimers Dis; 2024; 101(s1):S443-S453. PubMed ID: 39422952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy.
    Maurer GD; Brucker DP; Bähr O; Harter PN; Hattingen E; Walenta S; Mueller-Klieser W; Steinbach JP; Rieger J
    BMC Cancer; 2011 Jul; 11():315. PubMed ID: 21791085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ketotherapeutics for neurodegenerative diseases.
    Norwitz NG; Jaramillo JG; Clarke K; Soto A
    Int Rev Neurobiol; 2020; 155():141-168. PubMed ID: 32854853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's disease.
    Beckett TL; Studzinski CM; Keller JN; Paul Murphy M; Niedowicz DM
    Brain Res; 2013 Apr; 1505():61-7. PubMed ID: 23415649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders.
    Morris G; Maes M; Berk M; Carvalho AF; Puri BK
    Eur Psychiatry; 2020 Jan; 63(1):e8. PubMed ID: 32093791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.
    Maalouf M; Rho JM; Mattson MP
    Brain Res Rev; 2009 Mar; 59(2):293-315. PubMed ID: 18845187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A ketogenic diet substantially reshapes the human metabolome.
    Effinger D; Hirschberger S; Yoncheva P; Schmid A; Heine T; Newels P; Schütz B; Meng C; Gigl M; Kleigrewe K; Holdt LM; Teupser D; Kreth S
    Clin Nutr; 2023 Jul; 42(7):1202-1212. PubMed ID: 37270344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypometabolism as a therapeutic target in Alzheimer's disease.
    Costantini LC; Barr LJ; Vogel JL; Henderson ST
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S16. PubMed ID: 19090989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases.
    Jiang Z; Yin X; Wang M; Chen T; Wang Y; Gao Z; Wang Z
    Aging Dis; 2022 Jul; 13(4):1146-1165. PubMed ID: 35855338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.